JX7.F
EquityEmbecta Corp. R
Health Care · Medical Instruments & Supplies
Next Ex-Date: Feb 27, 2026 (Today!)
Buy before this date to receive the next dividend of $0.1269/share
$8.55
+8.55 (+0.00%)
Open
N/A
Day Range
$8.40 - $8.60
52W Range
$7.80 - $13.40
Volume
49
Price History
Key Statistics
Market Cap
N/A
P/E Ratio
N/A
EPS
N/A
Dividend Yield
N/A
P/B Ratio
N/A
Payout Ratio
N/A
ROE
N/A
Debt/Equity
N/A
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 11, 2026 |
POMEROY CLAIRE Director |
Other | 22,841 | $0.0 |
| Feb 11, 2026 |
MORRIS MILTON MAYO Director |
Other | 22,841 | $0.0 |
| Feb 11, 2026 |
ANDERSON CARRIE L Director |
Other | 22,841 | $0.0 |
| Feb 11, 2026 |
HOMBACH ROBERT J. CPA Director |
Other | 22,841 | $0.0 |
| Feb 11, 2026 |
REIDY CHRISTOPHER R Director |
Other | 22,841 | $0.0 |
| Feb 11, 2026 |
PRANGE KAREN N. Director |
Other | 22,841 | $0.0 |
| Nov 26, 2025 |
KURDIKAR DEVDATT Chief Executive Officer |
Other | 392,012 | $0.0 |
| Nov 26, 2025 |
ELGUICZE JACOB Chief Financial Officer |
Other | 125,613 | $0.0 |
| Nov 26, 2025 |
MANN JEFFREY Z General Counsel |
Other | 104,050 | $0.0 |
| Nov 26, 2025 |
CASNER JEAN Officer |
Other | 38,783 | $0.0 |
Institutional Ownership
| Holder | Shares | % Held | Value |
|---|---|---|---|
| Blackrock Inc. | 8,972,177 | 15.15% | $76.7M |
| American Century Companies Inc | 4,921,967 | 8.31% | $42.1M |
| Vanguard Group Inc | 4,617,610 | 7.80% | $39.5M |
| River Road Asset Management, LLC | 3,416,401 | 5.77% | $29.2M |
| Deerfield Management Company, L.P | 2,752,031 | 4.65% | $23.5M |
| State Street Corporation | 2,360,626 | 3.99% | $20.2M |
| Jefferies Financial Group Inc. | 2,354,971 | 3.98% | $20.1M |
| Yacktman Asset Management Lp | 2,262,915 | 3.82% | $19.3M |
| William Blair Investment Management, LLC | 1,568,414 | 2.65% | $13.4M |
| Geode Capital Management, LLC | 1,411,250 | 2.38% | $12.1M |
Latest News
Insurance Claims & Roofing: What Homeowners Need to Know After Winter Storms
Telo Genomics Corp. Announces Upsizing of Previously Announced Private Placement
As U.S. pressures Cuba, Trump says there could be 'friendly takeover'
Deals & Moves: EP Wealth, Captrust Pen 3rd Deals of 2026
Peers in Health Care
| Symbol | Name | Price | Mkt Cap | Div Yield | Change |
|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $116.32 | N/A | 2.06% | +0.00% |
| 001540.KQ | AHN-GOOK PHA | $8,070.00 | N/A | 5.45% | +0.00% |
| LLY | Eli Lilly and Company | $1,052.20 | N/A | 0.59% | +0.00% |
| NVO | Novo Nordisk A/S | $37.46 | N/A | 4.49% | +0.00% |
| EJG.F | EBOS Group Ltd. R | $11.70 | N/A | 5.14% | +0.00% |
| 5889.T | JAPAN EYEWEAR HOLDINGS CO LTD | $1,998.00 | N/A | 4.20% | +0.00% |
| 0332.KL | TOPVISN | $0.17 | N/A | 11.76% | +0.00% |
| ABBV | AbbVie Inc. | $230.81 | N/A | 2.88% | +0.00% |
About Embecta Corp. R
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
www.embecta.com →Dividend Safety
Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.
Borderline
Based on 4 fundamental factors
Analysis Tools
Share
Dividend History
Dividend Safety
Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.
Borderline
Based on 4 fundamental factors
Dividend Growth
1Y CAGR
+0.0%
3Y CAGR
+26.0%
5Y CAGR
N/A
10Y CAGR
N/A
5-Year Dividend Projection
| Year | Conservative | Base | Optimistic |
|---|
Based on historical CAGR. Not a guarantee of future dividends.
View Full Projection →Loading financial data...
Revenue & Earnings
No financial statement data available for JX7.F.